Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts. Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, et al. N Engl J Med 2023;389:205-214.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, et al. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts. N Engl J Med 2023;389:205-214.
PMID: 37272521